Cargando…
Failure to follow up on a medically actionable finding from direct to consumer genetic testing: A case report
BACKGROUND: A 61‐year‐old woman underwent direct to consumer genetic testing and was found to be homozygous for the C282Y HFE variant (c.845G>A :p.Cys282Tyr) which is classified as pathogenic/likely pathogenic for hereditary hemochromatosis. However, no action was taken by the individual. METHODS...
Autores principales: | Garmany, Ramin, Lee, Christopher J., Sharp, Richard R., Kullo, Iftikhar J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284021/ https://www.ncbi.nlm.nih.gov/pubmed/32329251 http://dx.doi.org/10.1002/mgg3.1252 |
Ejemplares similares
-
Direct-to-consumer genetic testing
por: Kim, Jong-Won
Publicado: (2019) -
Direct-to-consumer genetic testing
por: Horton, Rachel, et al.
Publicado: (2019) -
Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing
por: Carere, Deanna Alexis, et al.
Publicado: (2015) -
Direct-to-consumer genetic tests: beyond medical regulation?
por: Magnus, David, et al.
Publicado: (2009) -
Actionable Variants Identified by Genome Sequencing: Penetrance and Outcomes at 1-year Following Return to Participants
por: Lee, Christopher, et al.
Publicado: (2021)